Search - tctmd.com

Displaying 481 - 500 of 696

Sort: Relevancy | Date

News Daily News

Ethnic Variations in Lp(a) Concentrations Challenge Current Risk Thresholds

Yael L. Maxwell

January 25, 2019

News Daily News

Genetic Risk Factor Discovered for Spontaneous Coronary Artery Dissection

Todd Neale

January 18, 2019

News Daily News

Dose-Response Benefits for Fiber Intake Seen Across Wide Swath of Acquired Diseases

Shelley Wood

January 15, 2019

News Daily News

VTE Risk in Women May Be Higher With Oral vs Transdermal Hormone Replacement Therapies

L.A. McKeown

January 14, 2019

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Vote

News Daily News

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

Caitlin E. Cox

January 11, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2018

Caitlin E. Cox

January 01, 2019

News Features

Top News in Clinical Cardiology: 2018

Yael L. Maxwell

December 28, 2018

News Daily News

Data Hint at Unintended Consequences of Hospital Readmissions Reduction Program

L.A. McKeown

December 21, 2018

News Conference News WCC 2018

WHF Celebrates 40th Anniversary as World Congress Kicks Off in Dubai

Todd Neale

December 05, 2018

News Daily News

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Michael O'Riordan

December 04, 2018

News Daily News

Healthy Behaviors Linked to Lower Risk of Subclinical Atherosclerosis in Middle-aged Women

Yael L. Maxwell

November 30, 2018

News Daily News

Certain Risk Factors Carry Higher MI Risk in Women Than in Men

Shelley Wood

November 23, 2018

News Daily News

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

Michael O'Riordan

November 23, 2018

News Conference News AHA 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Michael O'Riordan

November 16, 2018

News Daily News

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

Caitlin E. Cox

November 15, 2018

News Conference News AHA 2018

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Michael O'Riordan

November 15, 2018

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Conference News AHA 2018

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Michael O'Riordan

November 14, 2018

News Conference News AHA 2018

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

Caitlin E. Cox

November 13, 2018

News Conference News AHA 2018

Novel Inhibitor of Apolipoprotein(a) Production Lowers Lp(a) in Phase II Study

Shelley Wood

November 11, 2018

Advertisement

Ethnic Variations in Lp(a) Concentrations Challenge Current Risk Thresholds

Genetic Risk Factor Discovered for Spontaneous Coronary Artery Dissection

Dose-Response Benefits for Fiber Intake Seen Across Wide Swath of Acquired Diseases

VTE Risk in Women May Be Higher With Oral vs Transdermal Hormone Replacement Therapies

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

TCTMD’s Top 10 Most Popular Stories for December 2018

Top News in Clinical Cardiology: 2018

Data Hint at Unintended Consequences of Hospital Readmissions Reduction Program

WHF Celebrates 40th Anniversary as World Congress Kicks Off in Dubai

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Healthy Behaviors Linked to Lower Risk of Subclinical Atherosclerosis in Middle-aged Women

Certain Risk Factors Carry Higher MI Risk in Women Than in Men

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

‘Accelerated Atherosclerosis’ Not Uncommon in Arteries of Young People

Alirocumab Should Be Priced at $6,300 Annually: ODYSSEY Cost-Effectiveness Study

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

Long-term FREEDOM: At Nearly 8 years, CABG Maintains Mortality Benefit Over PCI

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

Novel Inhibitor of Apolipoprotein(a) Production Lowers Lp(a) in Phase II Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content